Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03261999
Title Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors Foresee Pharmaceuticals Co., Ltd.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.